This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansen, M Articles by Barklis, E Search for Related Content PubMed PubMed Citation Articles by Hansen, M Articles by Barklis, E

 Previous Article  |  Next Article 

J Virol. 1990 November; 64(11): 5306-5316

Transport and assembly of gag proteins into Moloney murine leukemia virus.

Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland 97201.

ABSTRACT

We have studied the process of Moloney murine leukemia virus (M-MuLV) assembly by characterization of core (gag) protein mutants and analysis of wild-type (wt) gag proteins produced by cells in the presence of the ionophore monensin. Our genetic studies involved examination of linker insertion mutants of a Gag-beta-galactosidase (Gag-beta-gal) fusion protein, GBG2051, which is incorporated into virus particles when expressed in the presence of wt viral proteins. Analysis indicated that the amino-terminal two-thirds of the gag matrix domain is essential for targeting of proteins to the plasma membrane; mutant proteins localized to the cytoplasm or were trapped on intracellular membranes. Mutations through most of the coding region of the gag capsid domain generated proteins which were released from cells in membrane vesicles but not in virions. In contrast, linker insertions into p12gag or carboxy-terminal portions of the matrix or capsid coding regions did not affect assembly of fusion proteins into virus particles. Monensin, which blocks vesicular transport, inhibited gag protein intracellular transport and release from cells. Our results suggest that a significant proportion of M-MuLV myristylated gag proteins travel via vesicles to the cell surface. Specific matrix protein polypeptide regions and myristic acid modification are both necessary for appropriate gag protein transport, while capsid protein interactions appear to mediate the final phase of virion formation.

This article has been cited by other articles:

• Murphy, S. L., Gaulton, G. N. (2007). TR1.3 Viral Pathogenesis and Syncytium Formation Are Linked to Env-Gag Cooperation. J. Virol. 81: 10777-10785 [Abstract] [Full Text]  
• Barklis, E., Still, A., Sabri, M. I., Hirsch, A. J., Nikolich-Zugich, J., Brien, J., Dhenub, T. C., Scholz, I., Alfadhli, A. (2007). Sultam Thiourea Inhibition of West Nile Virus. Antimicrob. Agents Chemother. 51: 2642-2645 [Abstract] [Full Text]  
• Cartellieri, M., Herchenroder, O., Rudolph, W., Heinkelein, M., Lindemann, D., Zentgraf, H., Rethwilm, A. (2005). N-Terminal Gag Domain Required for Foamy Virus Particle Assembly and Export. J. Virol. 79: 12464-12476 [Abstract] [Full Text]  
• Ono, A., Freed, E. O. (2004). Cell-Type-Dependent Targeting of Human Immunodeficiency Virus Type 1 Assembly to the Plasma Membrane and the Multivesicular Body. J. Virol. 78: 1552-1563 [Abstract] [Full Text]  
• Andrawiss, M., Takeuchi, Y., Hewlett, L., Collins, M. (2003). Murine Leukemia Virus Particle Assembly Quantitated by Fluorescence Microscopy: Role of Gag-Gag Interactions and Membrane Association. J. Virol. 77: 11651-11660 [Abstract] [Full Text]  
• Fehrmann, F., Jung, M., Zimmermann, R., Krausslich, H.-G. (2003). Transport of the Intracisternal A-Type Particle Gag Polyprotein to the Endoplasmic Reticulum Is Mediated by the Signal Recognition Particle. J. Virol. 77: 6293-6304 [Abstract] [Full Text]  
• Wang, M. Q., Goff, S. P. (2003). Defects in Virion Production Caused by Mutations Affecting the C-Terminal Portion of the Moloney Murine Leukemia Virus Capsid Protein. J. Virol. 77: 3339-3344 [Abstract] [Full Text]  
• Scheifele, L. Z., Rhoads, J. D., Parent, L. J. (2002). Specificity of Plasma Membrane Targeting by the Rous Sarcoma Virus Gag Protein. J. Virol. 77: 470-480 [Abstract] [Full Text]  
• Le Blanc, I., Blot, V., Bouchaert, I., Salamero, J., Goud, B., Rosenberg, A. R., Dokhelar, M.-C. (2002). Intracellular Distribution of Human T-Cell Leukemia Virus Type 1 Gag Proteins Is Independent of Interaction with Intracellular Membranes. J. Virol. 76: 905-911 [Abstract] [Full Text]  
• Mariani, R., Rutter, G., Harris, M. E., Hope, T. J., Kräusslich, H.-G., Landau, N. R. (2000). A Block to Human Immunodeficiency Virus Type 1 Assembly in Murine Cells. J. Virol. 74: 3859-3870 [Abstract] [Full Text]  
• Ono, A., Orenstein, J. M., Freed, E. O. (2000). Role of the Gag Matrix Domain in Targeting Human Immunodeficiency Virus Type 1 Assembly. J. Virol. 74: 2855-2866 [Abstract] [Full Text]  
• Zhang, Y., Qian, H., Love, Z., Barklis, E. (1998). Analysis of the Assembly Function of the Human Immunodeficiency Virus Type 1 Gag Protein Nucleocapsid Domain. J. Virol. 72: 1782-1789 [Abstract] [Full Text]  
• Sharma, S., Murai, F., Miyanohara, A., Friedmann, T. (1997). Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents. Proc. Natl. Acad. Sci. USA 94: 10803-10808 [Abstract] [Full Text]